Bisphosphonate use and breast cancer recurrence risk in the QUILT cohort

被引：0
|
作者：
Korde, L. A.
Doody, D. R.
Malone, K. E.
机构：
[1] Univ Washington, Seattle, WA 98195 USA
[2] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.SABCS15-P5-15-03
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P5-15-03
引用
收藏
页数：2
相关论文
共 50 条
  • [41] NSAID use and breast cancer risk in a retrospective cohort of women with benign breast disease
    Degnim, Amy
    Vierkant, Robert
    Winham, Stacey
    Frost, Marlene
    Visscher, Daniel
    Carter, Jodi
    Kaggal, Suneetha
    Cunningham, Julie
    Allers, Teresa
    Hoskin, Tanya
    Heinzen, Ethan
    Vachon, Celine
    Knutson, Keith
    Knutson, Keith
    Radisky, Derek
    Sherman, Mark
    CANCER RESEARCH, 2020, 80 (04)
  • [42] Statin use and risk of contralateral breast cancer: a nationwide cohort study
    Rikke Langballe
    Deirdre Cronin-Fenton
    Christian Dehlendorff
    Maj-Britt Jensen
    Bent Ejlertsen
    Michael Andersson
    Søren Friis
    Lene Mellemkjær
    British Journal of Cancer, 2018, 119 : 1297 - 1305
  • [43] Use of Bisphosphonates and Risk of Breast Cancer in a French Cohort of Postmenopausal Women
    Fournier, Agnes
    Mesrine, Sylvie
    Gelot, Amandine
    Fagherazzi, Guy
    Baglietto, Laura
    Clavel-Chapelon, Francoise
    Boutron-Ruault, Marie-Christine
    Chabbert-Buffet, Nathalie
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (28) : 3230 - +
  • [44] Statin use and risk of contralateral breast cancer: a nationwide cohort study
    Langballe, Rikke
    Cronin-Fenton, Deirdre
    Dehlendorff, Christian
    Jensen, Maj-Britt
    Ejlertsen, Bent
    Andersson, Michael
    Friis, Soren
    Mellemkjaer, Lene
    BRITISH JOURNAL OF CANCER, 2018, 119 (10) : 1297 - 1305
  • [45] Decreased risk of breast cancer associated with oral bisphosphonate therapy
    Mathew, Aju
    Brufsky, Adam
    BREAST CANCER-TARGETS AND THERAPY, 2012, 4 : 75 - 81
  • [46] Bisphosphonate therapy for women with breast cancer and at high risk for osteoporosis
    Morris, Gloria J.
    Mitchell, Edith P.
    JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2007, 99 (01) : 35 - 45
  • [47] Bisphosphonate use in women with breast cancer on aromatase inhibitor therapy
    McGowan, A.
    van der Kamp, S.
    McKenna, M. J.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2014, 183 : S463 - S463
  • [48] New biomarkers for adjuvant bisphosphonate use in triplenegative breast cancer
    Sandholm, J. A.
    Petruk, N.
    Selander, K. S.
    Tuomela, J. M.
    CANCER RESEARCH, 2019, 79 (04)
  • [49] Multimodal Prediction of Breast Cancer Recurrence Assays and Risk of Recurrence
    Howard, Frederick M.
    Dolezal, James M.
    Kochanny, Sara
    Khramtsova, Galina
    Vickery, Jasmine
    Srisuwananukorn, Andrew
    Woodard, Anna
    Chen, Nan
    Nanda, Rita
    Perou, Charles
    Olopade, Olufunmilayo I.
    Huo, Dezheng
    Pearson, Alexander
    CANCER RESEARCH, 2023, 83 (05)
  • [50] Oral Bisphosphonate Use and Breast Cancer Incidence in Postmenopausal Women
    Chlebowski, Rowan T.
    Chen, Zhao
    Cauley, Jane A.
    Anderson, Garnet
    Rodabough, Rebecca J.
    McTiernan, Anne
    Lane, Dorothy S.
    Manson, JoAnn E.
    Snetselaar, Linda
    Yasmeen, Shagufta
    O'Sullivan, Mary Jo
    Safford, Monika
    Hendrix, Susan L.
    Wallace, Robert B.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (22) : 3582 - 3590
12345